Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quince Therapeutics, Inc. - Common Stock (NQ: QNCX )

0.8416 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 20, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 250
Open 0.8416
Bid (Size) 0.8045 (7)
Ask (Size) 1.040 (1)
Prev. Close 0.8416
Today's Range 0.8416 - 0.8416
52wk Range 0.5401 - 2.717
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Quince Therapeutics Provides Pipeline Update and Business Outlook for 2023
From Quince Therapeutics, Inc.
Via Business Wire

Performance

YTD
+16.89%
+16.89%
1 Month
-18.29%
-18.29%
3 Month
+31.50%
+31.50%
6 Month
-44.26%
-44.26%
1 Year
-58.13%
-58.13%

More News

Read More
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why CN Energy Group Shares Are Trading Lower By 47%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Heart Test Laboratories Are Trading Higher By 136%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Dow Gains Over 100 Points; Eastern Bankshares Shares Drop After Q4 Results
Via Benzinga
Why Applied UV Shares Are Trading Higher By 46%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Nasdaq Jumps 100 Points; Crude Oil Down 1%
Via Benzinga
KERN Stock Alert: Akerna Plans to Merge With Gryphon Digital Mining
Via InvestorPlace
Why Is Quince Therapeutics (NASDAQ:QNCX) Stock Up 53% Today?
Via InvestorPlace
Quince Therapeutics Completes the Sale of Legacy Protease Inhibitor Portfolio to Lighthouse Pharmaceuticals
From Quince Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Quince Therapeutics Presents Preclinical Data at MHSRS 2022 Demonstrating Preclinical Efficacy of Bone-targeting Platform for Traumatic Bone Injury
From Quince Therapeutics, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Quince Therapeutics Presents Preclinical Data at ASBMR 2022 Demonstrating Application of Bone-targeting Platform for Spinal Fusion and Bone Cancer Indications
From Quince Therapeutics, Inc.
Via Business Wire
Quince Therapeutics Presents Preclinical Data at OI 2022 Demonstrating Potential of a Targeted Anabolic for Accelerated Bone Healing of Osteogenesis Imperfecta Fractures
From Quince Therapeutics, Inc.
Via Business Wire
Quince Therapeutics to Present at Upcoming Scientific Meetings
From Quince Therapeutics, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.